Sterling Investment Advisors (Pennsylvania)’s ARK Genomic Revolution ETF ARKG Stock Holding History

Sterling Investment Advisors (Pennsylvania)’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13,865	Closed	-$637K	–	554
2022 Q1	$637K	Sell	13,865 -825	-6%	-$39.3K	0.18%	102
2021 Q4	$900K	Sell	14,690 -3,335	-19%	-$231K	0.25%	89
2021 Q3	$1.35M	Buy	18,025 +185	+1%	+$15.5K	0.4%	71
2021 Q2	$1.65M	Buy	17,840 +17,630	+8,395%	+$1.5M	0.48%	64
2021 Q1	$19K	Buy	210 +107	+104%	+$10.6K	0.01%	340
2020 Q4	$10K	Buy	+103	New	+$8.21K	﹤0.01%	364

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Sterling Investment Advisors (Pennsylvania)'s ARKG Position: Q2 2022 in Review

Sterling Investment Advisors (Pennsylvania) sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 13,865 shares — an estimated $637K sold.

Sterling Investment Advisors (Pennsylvania) first reported a position in ARKG in Q4 2020 and held it in 6 quarters. The position peaked at $1.65M in Q2 2021. 334 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

Sterling Investment Advisors (Pennsylvania) reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
Sterling Investment Advisors (Pennsylvania) sold 13,865 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $637K.
Sterling Investment Advisors (Pennsylvania) first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 6 quarters.
Sterling Investment Advisors (Pennsylvania)'s ARK Genomic Revolution ETF position peaked at $1.65M in Q2 2021.
334 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q2 2022, filed 5 Aug 2022.